Naomi Thomson

Naomi Thomson has over 35 years of work experience in various roles within the biotechnology and genomics industries. Naomi is currently serving as the Senior Director of Business Development at Indivumed Group, where they are responsible for their IndivuType platform, which provides comprehensive cancer data analysis and clinical profiles. Prior to that, they worked as an Ambassador at JADBio, focusing on applying machine learning algorithms to biomedical data analysis. Naomi also served as the Vice President of Clinical Genomics at BRIDGenomics, where they bridged the gap between diagnostic, pharmaceutical, and research sectors in genomics. Before that, they held positions at BlueBee, QIAGEN, CLC bio, Gene Codes Corporation, Kimeragen Inc., Bristol-Myers Squibb, and the Wistar Institute, where they gained expertise in areas such as business development, product management, customer care, training, and research.

Naomi Thomson has a Master of Business Administration (MBA) degree with a specialization in Information Technology from La Salle University. Naomi completed their MBA program from 1999 to 2004. Prior to that, they attended Bryn Mawr College from 1980 to 1984 and obtained a Bachelor of Science (BSc) degree in Biology, specializing in General Biology. Though no specific start or end years are mentioned, Naomi Thomson also received training from Bina Training, but the degree name and field of study are not provided. Additionally, they hold a certification as a Certified Six Sigma Yellow Belt from Epic Innovation, obtained in September 2019.